TauRx Hosts Event to Inform on bvFTD Trial at International Conference on Frontotemporal Dementias
TauRx Therapeutics Ltd, a spin-off company from the University of Aberdeen in Scotland, recently hosted a breakfast event to inform both patients and caregivers about their phase III clinical trial, which will test a treatment for behavioral variant Frontotemporal Dementia (bvFTD), and is currently enrolling participants. The “Meet the Experts” breakfast was held on …